O'Neill Institute  |  September 2, 2021

Read the Publication

HEPATITIS C VIRUS (HCV) INFECTIONS continue to be a public health threat in the United States. Several states have invested in innovative payment models to help eliminate cost and access barriers to HCV treatment for people on Medicaid and people in state-operated correctional systems. So far, Louisiana and Washington have implemented innovative payment models for treatment, and Michigan is currently taking steps to implement its model.

Read more here.

Related Projects

Hepatitis Policy Project

Latest publications See All

Report

October 14, 2025

Charles Holmes Maggie Little, Ph.D.; Heidi Weimer, J.D., MPH, LL.M; Dylan Green, MPH; Alicia Patterson, Ph.D.; Jonathan Healey; Sydney Luken; Janet Tatenda Bhila; Aleny Couto, MD; Shona Dalal, PhD; Will Fleisher, PhD; Jen Gennai; Rayid Ghani; Peter Godfrey-Faussett; Melissa Goldstein, JD; Kathy Hageman, PhD, MPH; Nina Hasen, PhD; Micheal Ighodaro; Thoko Kalua, MBBS, MSc; Jennifer Miller, PhD; Yogan Pillay, PhD; Anton Pozniak, MD; Miriam Rabkin, MD, MPH; David Ribes, PhD; Lisa Singh, PhD